Equity
Unrealized Gains on Investments
Eli Lilly Unrealized Gains on Investments decreased by 13.2% to $3.30M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 54.2%, from $7.20M to $3.30M. Over 4 years (FY 2020 to FY 2024), Unrealized Gains on Investments shows a downward trend with a -47.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryCapital Allocation
SignalHigher is better
VolatilityVolatile
First reportedQ3 2018
Last reportedQ4 2025
How to read this metric
Rising gains indicate strong performance of the underlying securities, whereas falling gains reflect market headwinds.
Detailed definition
This metric tracks the total positive difference between the fair market value and the amortized cost of investment secu...
Peer comparison
Commonly reported by all major banks; highly sensitive to interest rate fluctuations.
Metric ID:
unrealized_gains_on_investmentsHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $14.50M | $12.50M | $9.70M | $1.30M | $200.00K | $100.00K | $600.00K | $1.80M | $600.00K | $100.00K | $3.40M | $1.90M | $1.40M | $7.20M | $1.60M | $3.00M | $3.80M | $3.30M |
| QoQ Change | — | -13.8% | -22.4% | -86.6% | -84.6% | -50.0% | +500.0% | +200.0% | -66.7% | -83.3% | >999% | -44.1% | -26.3% | +414.3% | -77.8% | +87.5% | +26.7% | -13.2% |
| YoY Change | — | — | — | — | -98.6% | -99.2% | -93.8% | +38.5% | +200.0% | +0.0% | +466.7% | +5.6% | +133.3% | >999% | -52.9% | +57.9% | +171.4% | -54.2% |
Range$100.00K – $14.50M
CAGR-29.4%
Avg YoY Growth+555.3%
Median YoY Growth+22.0%
Unrealized Gains on Investments at Other Companies
Frequently Asked Questions
- What is Eli Lilly's unrealized gains on investments?
- Eli Lilly (LLY) reported unrealized gains on investments of $3.30M in Q3 2025.
- How has Eli Lilly's unrealized gains on investments changed year-over-year?
- Eli Lilly's unrealized gains on investments decreased by 54.2% year-over-year, from $7.20M to $3.30M.
- What is the long-term trend for Eli Lilly's unrealized gains on investments?
- Over 4 years (2020 to 2024), Eli Lilly's unrealized gains on investments has grown at a -47.4% compound annual growth rate (CAGR), from $20.90M to $1.60M.
- What does unrealized gains on investments mean?
- The total market value increase of investment securities that the bank still owns.